D. M. Vega

Aligning Tumor Mutational Burden (TMB) quantification across diagnostic platforms: Phase 2 of the Friends of Cancer Research TMB Harmonization Project.

A. Stenzinger, J. Budczies, Mingchao Xie, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO–Friends of Cancer Research Prior Therapies Work Group

Edward S. Kim, R. Schilsky, R. Osarogiagbon, 2021, Clinical Cancer Research.

Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

G. Rosner, A. Chaudhuri, G. Pennello, 2022, JCO precision oncology.

Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO–Friends of Cancer Research Joint Research Statement

Edward S. Kim, R. Schilsky, Caroline Schenkel, 2021, Clinical Cancer Research.

Patient, Family Member and Physician Perspectives and Experiences with AML Treatment Decision-Making

N. Russell, T. Leblanc, R. Walter, 2022, Oncology and Therapy.